Alliance Pharma plc (APH.L)

34.95 +0.05 (+0.14%) At close: 04:35PM BST

Alliance Pharma plc

Avonbridge House
Bath Road
Chippenham SN15 2BB
United Kingdom
44 12 4946 6966
https://www.alliancepharmaceuticals.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 285

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Andrew Timothy Franklin	Interim CEO, CFO & Executive Director	271.52k	N/A	1966
Mr. Peter Jonathan Butterfield	CEO & Executive Director (Leave of Absence)	399.83k	N/A	1976
Mr. Jeyan Heper (Hons), BA	COO & Director	N/A	N/A	1974
Mr. Stephen Kidner	Chief Scientific Affairs Officer	N/A	N/A	N/A
Ms. Cora Maeve McCallum C.F.A.	Head of Investor Relations & Corporate Communications	N/A	N/A	N/A
Mr. Christodoulos Theoclis Chrysanthou	Group General Counsel & Company Secretary	N/A	N/A	N/A
Mr. Alex Duggan	Chief Commercial & Corporate Development Officer	N/A	N/A	N/A
Julie Skinner	Chief People Officer	N/A	N/A	N/A
Chris Delafield	Global Marketing Head of Kelo-Cote	N/A	N/A	N/A
Rhodri Smith	Head of Sourcing	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

Corporate Governance

Alliance Pharma plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.